Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3128135rdf:typepubmed:Citationlld:pubmed
pubmed-article:3128135lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3128135lifeskim:mentionsumls-concept:C0014544lld:lifeskim
pubmed-article:3128135lifeskim:mentionsumls-concept:C0231335lld:lifeskim
pubmed-article:3128135lifeskim:mentionsumls-concept:C0205052lld:lifeskim
pubmed-article:3128135lifeskim:mentionsumls-concept:C0080356lld:lifeskim
pubmed-article:3128135lifeskim:mentionsumls-concept:C0007320lld:lifeskim
pubmed-article:3128135lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:3128135pubmed:issue6lld:pubmed
pubmed-article:3128135pubmed:dateCreated1988-5-12lld:pubmed
pubmed-article:3128135pubmed:abstractTextTwo children with status epilepticus were treated successfully by the rectal administration of valproate (VPA), and complete seizure control was obtained in one patient without severe side effects. In addition, there was no essential difference in pharmacokinetics between rectal and oral administration of VPA as determined by computerized simulation of plasma concentration data of VPA after rectal administration in two healthy adults or an epileptic child. Although these findings suggest that the early absorption of VPA within 30 minutes of rectal administration is slightly more rapid than that of oral administration, rectal VPA seems to be unsuitable for the first choice in the treatment of status epilepticus, since it has not so immediate effects as intravenous administration of DZP.lld:pubmed
pubmed-article:3128135pubmed:languageenglld:pubmed
pubmed-article:3128135pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3128135pubmed:citationSubsetIMlld:pubmed
pubmed-article:3128135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3128135pubmed:statusMEDLINElld:pubmed
pubmed-article:3128135pubmed:issn0387-7604lld:pubmed
pubmed-article:3128135pubmed:authorpubmed-author:KawaiIIlld:pubmed
pubmed-article:3128135pubmed:authorpubmed-author:SengokuAAlld:pubmed
pubmed-article:3128135pubmed:authorpubmed-author:KanazawaOOlld:pubmed
pubmed-article:3128135pubmed:issnTypePrintlld:pubmed
pubmed-article:3128135pubmed:volume9lld:pubmed
pubmed-article:3128135pubmed:ownerNLMlld:pubmed
pubmed-article:3128135pubmed:authorsCompleteYlld:pubmed
pubmed-article:3128135pubmed:pagination615-20lld:pubmed
pubmed-article:3128135pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3128135pubmed:meshHeadingpubmed-meshheading:3128135-...lld:pubmed
pubmed-article:3128135pubmed:meshHeadingpubmed-meshheading:3128135-...lld:pubmed
pubmed-article:3128135pubmed:meshHeadingpubmed-meshheading:3128135-...lld:pubmed
pubmed-article:3128135pubmed:meshHeadingpubmed-meshheading:3128135-...lld:pubmed
pubmed-article:3128135pubmed:meshHeadingpubmed-meshheading:3128135-...lld:pubmed
pubmed-article:3128135pubmed:meshHeadingpubmed-meshheading:3128135-...lld:pubmed
pubmed-article:3128135pubmed:meshHeadingpubmed-meshheading:3128135-...lld:pubmed
pubmed-article:3128135pubmed:year1987lld:pubmed
pubmed-article:3128135pubmed:articleTitleTreatment of childhood epilepsy with rectal valproate: case reports and pharmacokinetic study.lld:pubmed
pubmed-article:3128135pubmed:affiliationDepartment of Pediatrics, Utano National Hospital, Kyoto, Japan.lld:pubmed
pubmed-article:3128135pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3128135pubmed:publicationTypeCase Reportslld:pubmed